1.° Alexandri de Sancto Elpidio, ordinis Eremitarum sancti Augustini, tractatus de ecclesiastica potestate : inserta est donatio Constantini Magni facta Ecclesiae Romanae. — 2.° Ejusdem expositio in principium evangelii secundum Joannem. — 3.° Ejusdem epitome librorum sancti Augustini de civitate Dei. — 4.° Sancti Isidori, synonymorum, sive soliloquiorum liber. — 5.° Fratris Dionysii de Colle, ordinis Eremitarum sancti Augustini, tractatus de fato et praescientia divina. — 6.° Testimonia duodecim Patriarcharum de Christo. — 7.° Tractatus de Antichristo. — 8.° Excerptum ex tractatu Origenis de novem festivitatibus in Veteri Testamento. — 9.° Bernardi Oliverii, ordinis Eremitarum sancti Augustini, tractatus contra Judaeos. — 10.° Fratris Ricoldi, Florentini, ordinis Praedicatorum, disputatio contra Saracenos et Alcoranum. — 11.° Tractatus qui mensa pauperum inscribitur : authore A. ordinis Eremitarum sancti Augustini

Colbertinus

chartularium monasterii Longi-pontis, ordinis Cisterciensis, in dioecesi Suessionensi ; quod partim ex chartis, partim ex chartulario ejusdem monasterii Rogerius de Gaignieres describi curavit : praemittitur catalogus Abbatum monasterii Longi - pontis.

Rogerii de Gaignieres

chartularium monasterii Veteris-villae, ordinis Cisterciensis, in dioecesi Dolensi ; quod partim ex chartis, partim ex chartulario ejusdem monasterii Rogerius de Gaignieres describi curavit.

Rogerii de Gaignieres

1.° Jacobi Alexandri le Taneur disputatio physico-mathematica de aequabili motus acceleratione, et de motu telluris : in qua Galilaei decreta de motu gravium perpendiculariter cadentium confirmantur ; et ostenditur vulgarem seu Ptolemaïcam de motu solis opinionem non minùs esse contrariam sacris litteris, quam Copernicanam de motu terrae : ac proinde nihil certi ex iis, quoad illam quaestionem, posse deduci : ad Petrum Cazraeum, societatis Jesu. — 2.° Ejusdem epistolae duae ad eundem, de descensu gravium. — 3.° Petri Cazraei, societatis Jesu, ad Alexandrum le Taneur epistola, qua sententiam Galilaei de descensu gravium impugnat. — 4.° Lettre de monsieur le Taneur au Pere Mersenne, Minime, sur la chûte des corps. — 5.° Ejusdem ad eundem epistola contra Fabrianam de incremento motus accelerati opinionem.

Melchisedechi Thevenotii

Applications of the hexanic fraction of Agave sisalana Perrine ex Engelm (Asparagaceae): control of inflammation and pain screening

The present study evaluated the anti-inflammatory and analgesic properties of Agave sisalana Perrine in classic models of inflammation and pain. The hexanic fraction of A. sisalana (HFAS) was obtained by acid hydrolysis followed by hexanic reflux. Anti-inflammatory properties were examined in three acute mouse models (xylene ear oedema, hind paw oedema and pleurisy) and a chronic mouse model (granuloma cotton pellet). The antinociceptive potential was evaluated in chemical (acetic-acid) and thermal (tail-flick and hot-plate test) models of pain. When given orally, HFAS (5, 10, 25 and 50 mg/kg) reduced ear oedema (p < 0.0001; 52%, 71%, 62% and 42%, respectively). HFAS also reduced hind paw oedema at doses of 10 mg/kg and 25 mg/kg (p < 0.05; 42% and 58%, respectively) and pleurisy at doses of 10 mg/kg and 25 mg/kg (41% and 50%, respectively). In a chronic model, HFAS reduced inflammation by 46% and 58% at doses of 10 mg/kg and 25 mg/kg, respectively. Moreover, this fraction showed analgesic properties against the abdominal writhing in an acetic acid model (at doses of 5-25 mg/kg) with inhibitory rates of 24%, 54% and 48%. The HFAS also showed an increased latency time in the hot-plate (23% and 28%) and tail-flick tests (61% and 66%) for the 25 mg/kg and 50 mg/kg doses, respectively. These results suggest that HFAS has anti-inflammatory and analgesic properties.

PD-1 is a regulator of NY-ESO-1-specific CD8+ T cell expansion in melanoma patients.

The programmed death 1 (PD-1) receptor is a negative regulator of activated T cells and is up-regulated on exhausted virus-specific CD8(+) T cells in chronically infected mice and humans. Programmed death ligand 1 (PD-L1) is expressed by multiple tumors, and its interaction with PD-1 resulted in tumor escape in experimental models. To investigate the role of PD-1 in impairing spontaneous tumor Ag-specific CD8(+) T cells in melanoma patients, we have examined the effect of PD-1 expression on ex vivo detectable CD8(+) T cells specific to the tumor Ag NY-ESO-1. In contrast to EBV, influenza, or Melan-A/MART-1-specific CD8(+) T cells, NY-ESO-1-specific CD8(+) T cells up-regulated PD-1 expression. PD-1 up-regulation on spontaneous NY-ESO-1-specific CD8(+) T cells occurs along with T cell activation and is not directly associated with an inability to produce cytokines. Importantly, blockade of the PD-1/PD-L1 pathway in combination with prolonged Ag stimulation with PD-L1(+) APCs or melanoma cells augmented the number of cytokine-producing, proliferating, and total NY-ESO-1-specific CD8(+) T cells. Collectively, our findings support the role of PD-1 as a regulator of NY-ESO-1-specific CD8(+) T cell expansion in the context of chronic Ag stimulation. They further support the use of PD-1/PD-L1 pathway blockade in cancer patients to partially restore NY-ESO-1-specific CD8(+) T cell numbers and functions, increasing the likelihood of tumor regression.